The Impact of Extracellular Vesicle-Encapsulated Circulating MicroRNAs in Lung Cancer Research

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Fujita, Yu ^a   Kuwano, Kazuyoshi ^b   Ochiya, Takahiro ^a   Takeshita, Fumitaka ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESEARCH; CANCER SURVIVAL; CAUSE OF DEATH; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL GROWTH; CHEMICAL COMPOSITION; EARLY DIAGNOSIS; EXOSOME; EXTRACELLULAR SPACE; HUMAN; LUNG CANCER; MEMBRANE MICROPARTICLE; METASTASIS; MOLECULAR MECHANICS; PREDICTIVE VALUE; REVIEW; TREATMENT RESPONSE; BLOOD; DIAGNOSTIC USE; LUNG TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; TUMOR EMBOLISM;

CELL COMMUNICATION; EXOSOMES; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84917693100     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/486413     Document Type: Review

References (71)

1. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2013, " CA: Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11-30, 2013.
2. N. Kosaka, H. Iguchi, and T. Ochiya, "Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis, " Cancer Science, vol. 101, no. 10, pp. 2087-2092, 2010.
3. D. Baek, J. Villen, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, "The impact of microRNAs on protein output, " Nature, vol. 455, no. 7209, pp. 64-71, 2008.
4. B. R. Cullen, "Transcription and processing of human microRNA precursors, " Molecular Cell, vol. 16, no. 6, pp. 861-865, 2004.
5. Y. Lee, C. Ahn, J. Han, et al., "The nuclear RNase III Drosha initiates microRNA processing, " Nature, vol. 425, no. 6956, pp. 415-419, 2003.
6. M. V. Iorio and C. M. Croce, "MicroRNAdysregulation in cancer: diagnostics, monitoring and therapeutics. Acomprehensive review, " EMBO Molecular Medicine, vol. 4, no. 3, pp. 143-159, 2012.
7. J. Krol, I. Loedige, and W. Filipowicz, "The widespread regulation of microRNA biogenesis, function and decay, " Nature Reviews Genetics, vol. 11, no. 9, pp. 597-610, 2010.
8. H. Schwarzenbach, N. Nishida, G. A. Calin, and K. Pantel, "Clinical relevance of circulating cell-free microRNAs in cancer, " Nature Reviews Clinical Oncology, vol. 11, no. 3, pp. 145-156, 2014.
9. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function, " Cell, vol. 116, no. 2, pp. 281-297, 2004.
10. M. Inui, G. Martello, and S. Piccolo, "MicroRNA control of signal transduction, "Nature ReviewsMolecular Cell Biology, vol. 11, no. 4, pp. 252-263, 2010.
11. C. M. Croce, "Causes and consequences of microRNA dysregulation in cancer, " Nature Reviews Genetics, vol. 10, no. 10, pp. 704-714, 2009.
12. J. Lu, G. Getz, E. A. Miska, et al., "MicroRNA expression profiles classify human cancers, " Nature, vol. 435, no. 7043, pp. 834-838, 2005.
13. S. Volinia, G. A. Calin, C.-G. Liu, et al., "A microRNA expression signature of human solid tumors defines cancer gene targets, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
14. J. Takamizawa, H. Konishi, K. Yanagisawa, et al., "Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival, " Cancer Research, vol. 64, no. 11, pp. 3753-3756, 2004.
15. R. J. Webster, K. M. Giles, K. J. Price, P. M. Zhang, J. S. Mattick, and P. J. Leedman, "Regulation of epidermal growth factor receptor signaling in human cancer cells by MicroRNA-7, " The Journal of Biological Chemistry, vol. 284, no. 9, pp. 5731-5741, 2009.
16. M. W. Nasser, J. Datta, G. Nuovo, et al., "Down-regulation of micro-RNA-1 (miR-1) in lung cancer: suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1, " Journal of Biological Chemistry, vol. 283, no. 48, pp. 33394-33405, 2008.
17. G. J. Hurteau, J. A. Carlson, S. D. Spivack, and G. J. Brock, "Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin, " Cancer Research, vol. 67, no. 17, pp. 7972-7976, 2007.
18. M. Garofalo, C. Quintavalle, G. Di Leva, et al., "MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer, " Oncogene, vol. 27, no. 27, pp. 3845-3855, 2008.
19. Y. Hayashita, H. Osada, Y. Tatematsu, et al., "A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation, " Cancer Research, vol. 65, no. 21, pp. 9628-9632, 2005.
20. Y. Fujita, F. Takeshita, K. Kuwano, and T. Ochiya, "RNAi therapeutic platforms for lung diseases, " Pharmaceuticals, vol. 6, no. 2, pp. 223-250, 2013.
21. S.-L. Yu, H.-Y. Chen, G.-C. Chang, et al., "MicroRNA signature predicts survival and relapse in lung cancer, " Cancer Cell, vol. 13, no. 1, pp. 48-57, 2008.
22. R. S. Redis, S. Calin, Y. Yang, M. J. You, and G. A. Calin, "Cellto-cell miRNA transfer: from body homeostasis to therapy, " Pharmacology and Therapeutics, vol. 136, no. 2, pp. 169-174, 2012.
23. P. S. Mitchell, R. K. Parkin, E. M. Kroh, et al., "Circulating microRNAs as stable blood-based markers for cancer detection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513-10518, 2008.
24. J. D. Arroyo, J. R. Chevillet, E. M. Kroh, et al., "Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003-5008, 2011.
25. K. C. Vickers, B. T. Palmisano, B. M. Shoucri, R. D. Shamburek, and A. T. Remaley, "MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, " Nature Cell Biology, vol. 13, no. 4, pp. 423-433, 2011.
26. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. J. Lee, and J. O. Lotvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, " Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
27. C. Thery, "Exosomes: secreted vesicles and intercellular communications, " F1000 Biology Reports, vol. 3, no. 1, article 15, 2011.
28. Y. Fujita, Y. Yoshioka, S. Ito, J. Araya, K. Kuwano, and T. Ochiya, "Intercellular communication by extracellular vesicles and their microRNAs in Asthma, " Clinical Therapeutics, vol. 36, no. 6, pp. 873-881, 2014.
29. M. Redova, J. Sana, and O. Slaby, "Circulating miRNAs as new blood-based biomarkers for solid cancers, " Future Oncology, vol. 9, no. 3, pp. 387-402, 2013.
30. A. Zernecke, K. Bidzhekov, H. Noels, et al., "Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection, " Science Signaling, vol. 2, no. 100, Article IDra81, 2009.
31. C. Thery, M. Ostrowski, and E. Segura, "Membrane vesicles as conveyors of immune responses, " Nature Reviews Immunology, vol. 9, no. 8, pp. 581-593, 2009.
32. M. P. Hunter, N. Ismail, X. Zhang, et al., "Detectionof microRNA expression in human peripheral blood microvesicles, " PLoS ONE, vol. 3, no. 11, Article ID e3694, 2008.
33. J. F. Quackenbush, P. B. Cassidy, L. M. Pfeffer, et al., "Isolation of circulating microRNAs from microvesicles found in human plasma, " Methods in Molecular Biology, vol. 1102, pp. 641-653, 2014.
34. K. Rekker, M. Saare, A. M. Roost, et al., "Comparison of serum exosome isolation methods for microRNA prof iling, " Clinical Biochemistry, vol. 47, no. 1-2, pp. 135-138, 2014.
35. S. J. Gould and G. Raposo, "Aswewait: copingwith an imperfect nomenclature for extracellular vesicles, " Journal of Extracellular Vesicles, vol. 2, Article ID20389, 2013.
36. G. Raposo and W. Stoorvogel, "Extracellular vesicles: exosomes, microvesicles, and friends, " Journal of Cell Biology, vol. 200, no. 4, pp. 373-383, 2013.
37. T. Katsuda, N. Kosaka, F. Takeshita, and T. Ochiya, "The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles, " Proteomics, vol. 13, no. 10-11, pp. 1637-1653, 2013.
38. C. Bang and T. Thum, "Exosomes: new players in cell-cell communication, " The International Journal of Biochemistry & Cell Biology, vol. 44, no. 11, pp. 2060-2064, 2012.
39. J. Shen, S. A. Stass, and F. Jiang, "MicroRNAs as potential biomarkers in human solid tumors, " Cancer Letters, vol. 329, no. 2, pp. 125-136, 2013.
40. S. Gilad, E. Meiri, Y. Yogev, et al., "Serum microRNAs are promising novel biomarkers, " PLoS ONE, vol. 3, no. 9, Article ID e3148, 2008.
41. Z. Hu, X. Chen, Y. Zhao, et al., "Serum microRNA signatures identified in a genome-wide serum microRNA expression prof iling predict survival of non-small-cell lung cancer, " Journal of Clinical Oncology, vol. 28, no. 10, pp. 1721-1726, 2010.
42. C. H. Lawrie, S. Gal, H. M. Dunlop, et al., "Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma, " British Journal of Haematology, vol. 141, no. 5, pp. 672-675, 2008.
43. W. Zhu, W. Qin, U. Atasoy, and E. R. Sauter, "Circulating microRNAs in breast cancer and healthy subjects, " BMC Research Notes, vol. 2, article 89, 2009.
44. X. Chen, Y. Ba, L. Ma, et al., "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, " Cell Research, vol. 18, no. 10, pp. 997-1006, 2008.
45. W. Li, L. Xie, X. He, et al., "Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma, " International Journal of Cancer, vol. 123, no. 7, pp. 1616-1622, 2008.
46. M. Redova, A. Poprach, J. Nekvindova, et al., "Circulating miR and miR-451 in serum are potential biomarkers for renal cell carcinoma, " Journal of Translational Medicine, vol. 10, no. 1, article 55, 2012.
47. M. Hanke, K. Hoefig, H. Merz, et al., "A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer, " Urologic Oncology, vol. 28, no. 6, pp. 655-661, 2010.
48. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, "Characterization of extracellular circulating microRNA, " Nucleic Acids Research, vol. 39, no. 16, pp. 7223-7233, 2011.
49. Y. Yamamoto, N. Kosaka, M. Tanaka, et al., "MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma, " Biomarkers, vol. 14, no. 7, pp. 529-538, 2009.
50. H. M. Heneghan, N. Miller, A. J. Lowery, K. J. Sweeney, J. Newell, and M. J. Kerin, "Circulating microRNAs as novel minimally invasive biomarkers for breast cancer, " Annals of Surgery, vol. 251, no. 3, pp. 499-505, 2010.
51. Y. Yamada, H. Enokida, S. Kojima, et al., "MiR-96 and miR-183 detection in urine serve as potential tumormarkers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology, " Cancer Science, vol. 102, no. 3, pp. 522-529, 2011.
52. F. Bianchi, F. Nicassio, M. Marzi, et al., "A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer, " EMBO Molecular Medicine, vol. 3, no. 8, pp. 495-503, 2011.
53. J. Silva, V. Garcia, A. Zaballos, et al., "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival, " European Respiratory Journal, vol. 37, no. 3, pp. 617-623, 2011.
54. Q. Lin, W. Mao, Y. Shu, et al., "A cluster of specified microRNAs in peripheral blood as biomarkers formetastatic non-small-cell lung cancer by stem-loop RT-PCR, " Journal of Cancer Research and Clinical Oncology, vol. 138, no. 1, pp. 85-93, 2012.
55. J. Shen, N. W. Todd, H. Zhang, et al., "Plasma microRNAs as potential biomarkers for non-small-cell lung cancer, " Laboratory Investigation, vol. 91, no. 4, pp. 579-587, 2011.
56. J. Shen, J. Liao, M. A. Guarnera, et al., "Analysis of microRNAs in sputum to improve computed tomography for lung cancer diagnosis, " Journal of Thoracic Oncology, vol. 9, no. 1, pp. 33-40, 2014.
57. N. Li, J. Ma, M. A. Guarnera, H. Fang, L. Cai, and F. Jiang, "Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer, " Journal of Cancer Research and Clinical Oncology, vol. 140, no. 1, pp. 145-150, 2014.
58. M. Boeri, C. Verri, D. Conte, et al., "MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 9, pp. 3713-3718, 2011.
59. X.-G. Liu, W.-Y. Zhu, Y.-Y. Huang, et al., "High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer, " Medical Oncology, vol. 29, no. 2, pp. 618-626, 2012.
60. Z.-X. Wang, H.-B. Bian, J.-R. Wang, Z.-X. Cheng, K.-M. Wang, and W. De, "Prognostic significance of serum miRNA expression in human non-small cell lung cancer, " Journal of Surgical Oncology, vol. 104, no. 7, pp. 847-851, 2011.
61. E.-H. Cui, H.-J. Li, F. Hua, et al., "Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy, " Acta Pharmacologica Sinica, vol. 34, no. 2, pp. 309-313, 2013.
62. H. Wang, G. Tan, L. Dong, et al., "Circulating mir-125b as a marker predicting chemoresistance in breast cancer, " PLoS One, vol. 7, no. 4, Article IDe34210, 2012.
63. J. Skog, T. Wurdinger, S. van Rijn, et al., "Glioblastoma microvesicles transport RNAand proteins that promote tumour growth and provide diagnostic biomarkers, " Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
64. D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-Lawson, et al., "Functional delivery of viral miRNAs via exosomes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6328-6333, 2010.
65. Y. Zhang, D. Liu, X. Chen, et al., "Secreted monocytic miR-150 enhances targeted endothelial cell migration, " Molecular Cell, vol. 39, no. 1, pp. 133-144, 2010.
66. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya, "Secretory mechanisms and intercellular transfer of microRNAs in living cells, " The Journal of Biological Chemistry, vol. 285, no. 23, pp. 17442-17452, 2010.
67. T. Katsuda, N. Kosaka, and T. Ochiya, "Theroles of extracellular vesicles in cancer biology: toward the development of novel cancer biomarkers, " Proteomics, vol. 14, no. 4-5, pp. 412-425, 2014.
68. N. Kosaka, H. Iguchi, K. Hagiwara, Y. Yoshioka, F. Takeshita, and T. Ochiya, "Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic micrornas regulate cancer cell metastasis, " The Journal of Biological Chemistry, vol. 288, no. 15, pp. 10849-10859, 2013.
69. S. Rana, K. Malinowska, and M. Zoller, "Exosomal tumor microRNAmodulates premetastatic organ cells, " Neoplasia, vol. 15, no. 3, pp. 281-295, 2013.
70. M. Fabbri, A. Paone, F. Calore, et al., "MicroRNAs bind to Tolllike receptors to induce prometastatic inflammatory response, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 31, pp. E2110-E2116, 2012.
71. W. Zhou, M. Y. Fong, Y. Min, et al., "Cancer-Secreted miR-105 destroys vascular endothelial barriers to promote metastasis, " Cancer Cell, vol. 25, no. 4, pp. 501-515, 2014.